# Embold Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/embold-health

- Industry: Healthcare IT
- Headquarters: Nashville, US
- Website: www.emboldhealth.com
- Total disclosed funding: $23M
- Latest round: Series B (Mar 17, 2022)
- Investors on record: 4

## About

Embold Health, Inc. is a healthcare technology company that utilizes AI-driven solutions to enhance healthcare navigation and decision-making for employees and health plan members, ultimately improving care experiences and outcomes.Founded in 2017 in Nashville, US, Embold Health, Inc. focuses on providing innovative healthcare navigation solutions. The company has secured a total of USD 11.00 mn through 3 funding deals. Its latest funding round was a Series B, completed in March 2022, led by Echo Health Ventures with participation from Chrysalis Ventures, Morgan Health, and Whistler Capital Partners. CEO Daniel Stein is among the founders, which include Dmytro Fishman, Helena Ije, Martin Reim, Priit Salumaa, and Vitalii Lakusta.Embold Health offers a suite of AI-driven healthcare solutions designed to enhance the care experience for employees and members of health plans. The core product is a next-generation navigation tool that utilizes sophisticated analytics to guide users in making informed healthcare decisions. This tool is particularly effective in addressing the challenge of finding quality healthcare providers, thereby improving health outcomes while reducing costs. The company serves a diverse client base that includes employers looking to optimize their employees' healthcare experience and health plans aiming to improve member care. Embold Health's solutions are deployed across various geographical markets in the United States, leveraging aggregated claims data from over 230 million individuals for meaningful evaluations of healthcare providers across specialties.Embold Health generates revenue through a business-to-business (B2B) model by offering subscription-based services to employers and health plans. Clients engage with the firm to access its proprietary navigation tools and analytics, which help manage healthcare costs and enhance member satisfaction. The typical transaction structure involves annual service agreements, where clients pay for access to Embold’s platform that drives engagement and supports better healthcare choices for their employees or members. The company's flagship offerings and analytics capabilities are central to its revenue model, emphasizing its role in improving healthcare outcomes while maintaining cost efficiency.
In June 2025, Quantum Health, Inc., a portfolio company of Warburg Pincus and Great Hill Partners, agreed to acquire Embold Health, Inc. from Morgan Health, Whistler Capital Partners, Chrysalis Ventures, and Echo Health Ventures. Financial terms of the transaction were not disclosed.

## Funding rounds

- Series B, Mar 17, 2022, $11M — Chrysalis Ventures, Echo Health Ventures, Whistler Capital Partners, Morgan Health
- Series B, Dec 3, 2021, $12M — Echo Health Ventures

## Investors

- Echo Health Ventures (https://capitalatlas.ai/funds/echo-health-ventures) — Series B
- Chrysalis Ventures (https://capitalatlas.ai/funds/chrysalis-ventures) — Series B
- Whistler Capital Partners (https://capitalatlas.ai/funds/whistler-capital-partners) — Series B
- Morgan Health — Series B